• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法中使用的甲基氨基乙酰丙酸薄层是否足够?

Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?

作者信息

Wiegell Stine R, Lerche Catharina M, Wulf Hans Christian

机构信息

Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

出版信息

Photodermatol Photoimmunol Photomed. 2016 Mar;32(2):88-92. doi: 10.1111/phpp.12227. Epub 2015 Dec 15.

DOI:10.1111/phpp.12227
PMID:26577455
Abstract

BACKGROUND

If the recommended 1.0 mm layer of methyl aminolevulinate (MAL) is used during photodynamic therapy (PDT) of large areas with multiple actinic keratoses (AK) huge amounts of cream are needed.

OBJECTIVES

To report the amount of MAL used for PDT of AK and basal cell carcinomas (BCC) in daily routine. The association of protoporphyrin IX (PpIX) fluorescence and thickness of MAL was investigated in a randomized paired study in healthy volunteers.

METHODS

Amount of cream used per cm(2) during conventional and daylight PDT was recorded. In 16 healthy volunteers, 0.1 mm, 0.2 mm, 0.5 mm and 1.0 mm MAL cream were applied for 3 h on tape-stripped areas on each forearm randomized to light-permeable or light-impermeable occlusion. PpIX fluorescence was measured.

RESULTS

Less than 0.4 mm MAL was used during PDT of BCC and 0.2 mm for AK. No difference in PpIX fluorescence was found between the different thicknesses of MAL using light-impermeable occlusion.

CONCLUSION

In daily routine <0.4 mm MAL was used during PDT of BCC and 0.1-0.2 mm MAL during PDT of AK. The recommended 1.0 mm MAL did not result in a higher accumulation of PpIX compared to thinner MAL layers after light-impermeable occlusion for 3 h.

摘要

背景

在对大面积多发光化性角化病(AK)进行光动力疗法(PDT)时,如果使用推荐的1.0毫米厚的甲基氨基酮戊酸(MAL)乳膏,需要大量的乳膏。

目的

报告日常工作中用于AK和基底细胞癌(BCC)光动力治疗的MAL用量。在一项针对健康志愿者的随机配对研究中,研究了原卟啉IX(PpIX)荧光与MAL厚度之间的关系。

方法

记录常规光动力治疗和日光光动力治疗期间每平方厘米使用的乳膏量。在16名健康志愿者中,将0.1毫米、0.2毫米、0.5毫米和1.0毫米的MAL乳膏分别涂于每个前臂经胶带剥离的区域,随机采用透光或不透光封闭,持续3小时。测量PpIX荧光。

结果

BCC光动力治疗期间使用的MAL厚度小于0.4毫米,AK光动力治疗期间使用的MAL厚度为0.2毫米。采用不透光封闭时,不同厚度的MAL之间PpIX荧光无差异。

结论

在日常工作中,BCC光动力治疗期间使用的MAL厚度小于0.4毫米,AK光动力治疗期间使用的MAL厚度为0.1 - 0.2毫米。在不透光封闭3小时后,与较薄的MAL层相比,推荐的1.0毫米MAL并未导致更高的PpIX蓄积。

相似文献

1
Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?光动力疗法中使用的甲基氨基乙酰丙酸薄层是否足够?
Photodermatol Photoimmunol Photomed. 2016 Mar;32(2):88-92. doi: 10.1111/phpp.12227. Epub 2015 Dec 15.
2
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.实时皮肤氨基酮戊酸光动力疗法(MAL-PDT)期间原卟啉IX光漂白与后续临床结果之间的关系。
Lasers Surg Med. 2010 Sep;42(7):613-9. doi: 10.1002/lsm.20943.
3
Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.外用氨基酮戊酸光动力疗法(MAL-PDT)治疗光化性角化病和基底细胞癌的临床疗效及成本效益的真实世界实践研究
Eur J Dermatol. 2008 Sep-Oct;18(5):539-46. doi: 10.1684/ejd.2008.0469. Epub 2008 Aug 8.
4
Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.甲氨基酮戊酸涂敷于面部和头皮后,无论是否先进行刮除术,原卟啉 IX 的形成情况。
Photodiagnosis Photodyn Ther. 2018 Jun;22:155-157. doi: 10.1016/j.pdpdt.2018.03.008. Epub 2018 Mar 27.
5
Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.持续超低强度人工日光在多形性日光疹的光动力疗法中不如红色 LED 光有效。
Photodermatol Photoimmunol Photomed. 2011 Dec;27(6):280-5. doi: 10.1111/j.1600-0781.2011.00611.x.
6
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.原卟啉 IX 蓄积增加不能提高光动力疗法治疗光化性角化病的疗效:一项随机对照试验。
Br J Dermatol. 2017 May;176(5):1241-1246. doi: 10.1111/bjd.15098. Epub 2017 Mar 8.
7
[Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].[日光氨基乙酰丙酸光动力疗法治疗光化性角化病的操作流程]
Ann Dermatol Venereol. 2016 Apr;143(4):257-63. doi: 10.1016/j.annder.2016.02.016. Epub 2016 Mar 22.
8
Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.应用分幅 CO2 激光强化光动力疗法治疗光化性角化病:一项随机临床试验。
Br J Dermatol. 2012 Jun;166(6):1262-9. doi: 10.1111/j.1365-2133.2012.10893.x.
9
Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.外用甲基氨基乙酰丙酸进行日光光动力疗法治疗光化性角化病患者:意大利南部的初步经验
G Ital Dermatol Venereol. 2016 Apr;151(2):154-9. Epub 2014 Oct 3.
10
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.0.5%秋水仙碱乳膏与 5-氨基酮戊酸光动力疗法治疗前臂光化性角化病和皮肤原位癌的疗效和安全性:一项随机对照试验。
Br J Dermatol. 2018 Nov;179(5):1081-1087. doi: 10.1111/bjd.16824. Epub 2018 Sep 25.

引用本文的文献

1
The use of photodynamic therapy in medical practice.光动力疗法在医学实践中的应用。
Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024.